Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Elaine L Mills"'
Autor:
Barbara J Law, David Draper, Elaine L Mills, Manon Allard, Cheri Nijssen-Jordan, Robert Bortolossi, Noni E MacDonald, Abdulaziz A Al-Twaim, William Albritton, Gordon Kasian, Lottie Rea, Sharon Cronk, Robert Morris
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 1, Iss 1, Pp 15-22 (1990)
Epiglottitis is an acute, life threatening infection usually caused by Haemophilus influenzae type b. Although antibiotic therapy is an important part of management, the optimal route and duration is unknown. A multicentre retrospective review of 305
Externí odkaz:
https://doaj.org/article/f099f42b463042f3be1558d924dad73f
Publikováno v:
Vaccine. 25:8172-8179
Persistence of antibodies following a single dose of Tdap vaccine (tetanus, diphtheria, and five-component acellular pertussis vaccine for use in individuals past childhood) was evaluated in a follow-up of adolescents (N=324) and adults (N=644) who h
Autor:
Francisco Diaz-Mitoma, Joanne M. Langley, Elaine L. Mills, Marc Dionne, Roland Guasparini, Paul Whitstitt, Antigona Tomovici, Bruce Tapiero, Barbara Law, Gerald Predy, Scott A. Halperin
Publikováno v:
Vaccine. 25:1121-1125
In Canada, the fifth dose of the routine childhood immunization schedule against diphtheria, tetanus, pertussis and polio is given at 4-6 years of age. Up to 30% of children may have significant local reactions (redness, swelling) and this may be rel
Autor:
David W. Scheifele, Garry Humphreys, Roland Guasparini, Scott A. Halperin, Luis Barreto, Bruce Smith, Elaine L Mills
Publikováno v:
Vaccine. 21:2298-2306
We performed a randomized, controlled clinical trial to characterize the evolution of the adverse events associated with the fifth consecutive dose of an acellular pertussis vaccine, and to assess the level of discomfort associated with the injection
Autor:
Kate N. Culman, Alison L. Jenkins, Theresa W. Gyorkos, Gary Pekeles, Elaine L. Mills, Brian J. Ward
Publikováno v:
International Journal of Circumpolar Health; Vol 62, No 1 (2003)
Background. Inuit infants throughout the Arctic experience higher mortality and poorer health than their non-Inuit counterparts, and suffer disproportionately from bacterial and viral infections. Study design. This review examines the health status o
Autor:
Scott A. Halperin, Elaine L Mills, John J. Treanor, Taoufik Mabrouk, Pierre Trépanier, Marc Germain, Thomas Hassell, Richard Gauthier, Bruce Smith
Publikováno v:
Vaccine. 20:1240-1247
We performed randomized, double-blind, controlled trials to assess the safety and immunogenicity of an inactivated, Madin Darby Canine Kidney (MDCK)-derived cell line produced influenza vaccine in healthy adults (19-50 years), children (3-12 years) a
Autor:
Barbara Law, Marc H. Lebel, David W. Scheifele, Gold R, Elaine L. Mills, Morris R, Philippe Duclos, Scott A. Halperin, Noni E. MacDonald, Victor Marchessault, Taj Jadavji, Wendy Vaudry, Pierre Déry
Publikováno v:
The Pediatric Infectious Disease Journal. 19:1053-1059
Background. Varicella vaccine was approved for use in Canada in 1998. A major goal of universal varicella vaccine programs is to reduce severe infection and associated complications. Baseline data are essential against which to judge the effectivenes
Autor:
Pierre Lavigne, Carolyn Pim, William Meekison, Elaine L. Mills, Bruce Smith, Paul Hasselback, Luis Barreto, David W. Scheifele, Margaret L. Russell, Robert A. Parker, Scott A. Halperin
Publikováno v:
The Pediatric Infectious Disease Journal. 19:276-283
Pertussis is increasingly recognized as an important cause of cough illness in adolescents and adults.To evaluate the safety and antibody response to a single dose of an adult formulation of a five component (pertussis toxoid, filamentous hemagglutin
Autor:
Noni E. MacDonald, Robert F. Morris, Wendy Vaudry, Taj Jadavji, Gilles Delage, Barbara Law, Elaine L. Mills, Marc H. Lebel, Elaine E. L. Wang, Philippe Duclos, David W. Scheifele, Pierre Déry, Scott A. Halperin
Publikováno v:
Clinical Infectious Diseases. 28:1238-1243
To assess the morbidity associated with the continued high levels of pertussis, we studied all children2 years of age who were admitted to the 11 Immunization Monitoring Program--Active (IMPACT) centers, which constitute 85% of Canada's tertiary care
Autor:
Les Cunning, Melody Boyd, John Thipphawong, Roland Guasparini, Ronald Gold, Elaine L Mills, William Meekison, Margaret L. Russell, Fang Xie, Luis Barreto, Dana Harrison
Publikováno v:
Vaccine. 16:576-585
Safety, immunogenicity and lot consistency of five-component pertussis combination vaccine (CPDT-IPV/PRP-T) in infants were compared to that of whole cell pertussis combination vaccine (DPT-IPV//PRP-T), as were separate and combined injections of CPD